chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever 100.7; Dizziness; Headache; This is a spontaneous report from a contactable non-healthcare professional as a parent. A 22-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) as a first dose on 22Feb2021 at 14:00 pm in the left arm and as a second dose (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) on 14Mar2021 at 10:00 am in the left arm for COVID-19 vaccination. Medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021 at 10:00 am, the patient had fever 100.7, dizziness and headache started about 24 hours after vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive treatment for adverse events. The outcome of the events was reported as recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.
Pfizer Covid 19 the patient presented at the end of her Observation time with a complaint of a metalic taste in her mouth. Heartland was contacted and created incident # 2021-00020461. The patient denied treatment or transport, and her husband said they would take her to the ED if necessary.
pt started with sore arm, chest discomfort, fever, and fatigue. Pt still having symptoms today of chest pain and fatigue
received an only dluent part of Menveo Dose; received an only dluent part of Menveo Dose; This case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 12-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA586A, expiry date 31st August 2022) for prophylaxis.   On 19th November 2021, the patient received Menveo. On 19th November 2021, unknown after receiving Menveo, the patient experienced inappropriate dose of vaccine administered and inappropriate preparation of medication. On an unknown date, the outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were unknown.  Additional details were reported as follows: The patient received only diluent part of Menveo dose, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.
autoimmune disease that they cannot pinpoint; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the parent.  A female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization. The following information was reported: AUTOIMMUNE DISORDER (hospitalization, medically significant), outcome "unknown", described as "autoimmune disease that they cannot pinpoint".  Clinical course: The reporter stated that last year she was vaccinated at the medical center with her second dose she and she had shingles. Mentioned that ever since she has experienced tremendous pain in her arm after she was vaccinated. Stated that she has a 33 year old grandson who got vaccinated and had erratic blood pressure. Also, she has a daughter who held her sister's hand when she came off the ventilator who now has autoimmune disease that they cannot pinpoint. The patient was in the hospital for 4.5 months. Has had two doses of the vaccine. Clarified that she had the Pfizer vaccine. Her conditions did not happen until 5-6 months then she came down with it. Later clarified she is unsure if it was the Pfizer or Moderna vaccine that she had because she worked with the school system. Unable to determine which vaccine she had.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Migraine; nausea; dizziness; hot cold sweats; bad calf pain; chest pain; chest pressure; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in Arm Left on 02Oct2021 10:15 (Lot Number: Ff8839) as single dose for covid-19 immunisation at the age of 38-year-old.  Medical history included anaemia and known allergies: acetylsalicylic acid (ASPIRIN), codeine, shellfish. Patient had no covid prior vaccination. Concomitant medication included ferrous sulfate (IRON). No other vaccine in four weeks were taken. The patient experienced migraine, nausea, dizziness, hot cold sweats, bad calf pain, chest pain, chest pressure on 02Oct2021 15:00 PM. These events resulted in emergency room/department or urgent care and hospitalization. Patient was in hospitalization for 2 days. Th patient received treatment Ativan, Zofran, IV for events. Patient had tested covid post vaccination. The patient underwent lab tests and procedures which included rapid test (nasal swab): negative on 04Oct2021. Outcome of events was resolved with sequel in Oct2021.   Follow-up attempts are completed. No further information is expected.
Red, raised welt on upper arm. Patient reported she had swelling, redness and warmth from the shoulder to the elbow. Welt has been present for 3 days. Swelling of upper arm for 2 days. Warmth has been present for 3 days. She stayed quiet and rested over the weekend. She didn't try any medications, ice etc.
Difficulty breathing, red lumps on face & lips, sl swelling of face feeling of tightness in throat; tx w/Epinephrine 0.3mg SC;
covid positive 2/05/2021 with symptom onset 1/31/2021 after first dose
1 week after vaccine, had heaviness and sharp upper chest pain without radiation. Exacerbated by deep inspiration.
got the booster the side effects were really bad; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (got the booster the side effects were really bad) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (got the booster the side effects were really bad). At the time of the report, VACCINATION COMPLICATION (got the booster the side effects were really bad) outcome was unknown.            Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-377738 (Patient Link).
mental illness; This is a spontaneous report from a Pfizer-sponsored program. A contactable healthcare professional reported that a 54-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration from an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced mental illness on an unspecified date. The outcome of event was unknown.   No follow-up attempts are possible. No further information is expected.
After the vaccine my son began to walk in a feet's tip and he began to present serious sensory problems. He have after the vaccine serious and grave problems in his intestine and immunology like a candida albicans. he have special diets now.
Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Headache-Medium, Systemic: Unable to Sleep-Severe, Additional Details: local site reaction, patient did not seek outside medical care
Severe chills, rigors, fever, generalized aching from 10pm - 2 am the night of vaccine.
Itchy, red rash at site of injection occurring one day after administration. Rash is 8 inches in diameter and is still prominent after 3 weeks.
Received Influenza Vaccine on 9/23/15, via IM injection in the left shoulder. The vaccine was administered high on the shoulder, close to the deltoid muscle region. Patient has had pain the area, radiating down the left arm towards the back ever since  . Also left finger tingling.
soreness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the site of injection) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for Covid-19 Vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness at the site of injection). At the time of the report, VACCINATION SITE PAIN (soreness at the site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
patient reported to pharmacy 12/5/20- right arm was swollen, red, and warm. he said he developed red rash like patches that went from his lower back to his neck and extended down the right upper arm. patient also stated that the rash had improved since it developed.
unconsolable crying since immun given (4 1/2) hrs rt thigh a little red, warm & tender to touch; had 1 dose of APAP @ time of immun; brought back to clinic in PM; cool compress & leg & 2nd dose of APAP; DT only in future;
Breast tenderness, abdominal (uterine) sharp pain, chills, soreness at injection site
itching on my left arm and left hand/My right side arm also itched/The right side of my body also itched in the palm of my hand/breast also itched; bruising on both sides of my body; welts on both sides of my body; when she scratched the breast sores developed; sore right arm shoulder deltoid muscle; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on my left arm and left hand/My right side arm also itched/The right side of my body also itched in the palm of my hand/breast also itched), CONTUSION (bruising on both sides of my body), URTICARIA (welts on both sides of my body), BREAST PAIN (when she scratched the breast sores developed) and MYALGIA (sore right arm shoulder deltoid muscle) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included DIPHENHYDRAMINE and DIPHENHYDRAMINE HYDROCHLORIDE (ANTI ITCH CREAM [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (sore right arm shoulder deltoid muscle). On an unknown date, the patient experienced PRURITUS (itching on my left arm and left hand/My right side arm also itched/The right side of my body also itched in the palm of my hand/breast also itched), CONTUSION (bruising on both sides of my body), URTICARIA (welts on both sides of my body) and BREAST PAIN (when she scratched the breast sores developed). At the time of the report, PRURITUS (itching on my left arm and left hand/My right side arm also itched/The right side of my body also itched in the palm of my hand/breast also itched), CONTUSION (bruising on both sides of my body), URTICARIA (welts on both sides of my body), BREAST PAIN (when she scratched the breast sores developed) and MYALGIA (sore right arm shoulder deltoid muscle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.   This case was linked to MOD-2021-291452 (Patient Link).
Local reaction with swelling and redness upper thigh to just below knee right leg.  Recheck visit with nurse practitioner on 3-21-08.
Severe chest pain - light headness.  Dizzy - headache - masking heart symptoms - checked out in ER at hospital.
1/22 vaccination That evening, I started to cough. It got a little worse over next couple of days. I called my Dr office to check and see if a side affect on Monday after vaccination. They scheduled me for a COVID test. Prescribed inhaler and medication which helped the cough lessen by Thurs/Friday of that week.
Shortness of breath; throat swelling (transient). Symptoms lasted 15 minutes; vitals stable. No medication administered.
Immediate reaction post injection. Rapid heart rate along with dizziness. Lasted 30-45 minutes.
Started itchy while sleeping. When awoke was red, warm, swollen, itchy & hard. Swelling increased over a few days. Took about 10 days for symptoms to go away.
Soreness at injection site x 2 weeks hurts to lift. Patient taking Advil and applying ice.
This spontaneous report as received from a Licensed Practical Nurse refers to a female patient of unknown age. The nurse reported that patient started CERVARIX (manufacturer unspecified) when she was over 26 years of age and will receive a dose of GARDASIL to complete the HPV series on 24-JUL-2012. No adverse effects reported. Additional information has been requested.
8 days post vax, pt presented  to a physician "covered with pox". There were definitely more than 20 skin lesions and there may have been greater than 50 lesions. Follow-up information from a physician, reported that the pt's condition was "uncomplicated" and that the pt has recovered.
red lower eyelids; swollen lower eyelids; crusting on the lower eyelids; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA OF EYELID (red lower eyelids), SWELLING OF EYELID (swollen lower eyelids) and SCAB (crusting on the lower eyelids) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced ERYTHEMA OF EYELID (red lower eyelids), SWELLING OF EYELID (swollen lower eyelids) and SCAB (crusting on the lower eyelids). At the time of the report, ERYTHEMA OF EYELID (red lower eyelids), SWELLING OF EYELID (swollen lower eyelids) and SCAB (crusting on the lower eyelids) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment include Triple antibiotic eye ointment   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Patient stated that She wasn't sure if the AE were because of the vaccine. She usually has allergies anyway. It lasted for only two days.She didn't want to follow-up and asked to close the case.
This spontaneous report was received from Licensed Practical Nurse referring to an unspecified number of patients of unknown age. Nurse reported that unspecified number of improperly stored VAQTA, (lot # not reported). Doses had been administered to unspecified number of patients. Vaccines were exposed to 50F for 48 hours. No adverse effects reported. This is one of several reports from the same reporter source. Additional information is not expected.
Patient states productive cough starting yesterday, reports exposure to Covid 2 nights ago from daughter. KEY SYMPTOMS AND ASSESSMENT:9/29/21  Cough congestion and chest pain with coughing. No fever. Positive for COVID on 9/28/21. Pt not using OTC cough medication. Cough drops helping some. Tylenol as needed helps a little. ADLs effected by situation. Cough producitve per pt clear to yellow.
My migraines have gotten worse; dizzy spells; My allergies have gotten worse; Don't eat much; My arm is still sore from where the injection was; nausea; High fever; Intravenous route of administration; Body felt like brittle glass; cold sweat; dehydrated; trouble breathing; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweat), DEHYDRATION (dehydrated), DYSPNOEA (trouble breathing), MIGRAINE (My migraines have gotten worse) and BODY DYSMORPHIC DISORDER (Body felt like brittle glass) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Migraine NOS. Concurrent medical conditions included Food allergy and Chemical sensitivity.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced COLD SWEAT (cold sweat), DEHYDRATION (dehydrated), DYSPNOEA (trouble breathing), BODY DYSMORPHIC DISORDER (Body felt like brittle glass), NAUSEA (nausea), PYREXIA (High fever) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Intravenous route of administration). On an unknown date, the patient experienced MIGRAINE (My migraines have gotten worse), DIZZINESS (dizzy spells), HYPERSENSITIVITY (My allergies have gotten worse), EATING DISORDER (Don't eat much) and INJECTION SITE PAIN (My arm is still sore from where the injection was). On 10-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Intravenous route of administration) had resolved. At the time of the report, COLD SWEAT (cold sweat), DEHYDRATION (dehydrated), DYSPNOEA (trouble breathing), BODY DYSMORPHIC DISORDER (Body felt like brittle glass), NAUSEA (nausea) and PYREXIA (High fever) had not resolved and MIGRAINE (My migraines have gotten worse), DIZZINESS (dizzy spells), HYPERSENSITIVITY (My allergies have gotten worse), EATING DISORDER (Don't eat much) and INJECTION SITE PAIN (My arm is still sore from where the injection was) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
Patient is experiencing increased redness, tenderness and a bump increasing in size at the injection site one-week after injection. Pharmacist recommended that patient go to Urgent Care to receive care for potential allergic reaction.
Initial report received from a healthcare professional on 15 Jan 2010: This patient, who was a 1 year old child, received FLUVIRIN lot no. 102140P1, 0.5 ml intramuscular on 14 Jan 2010. No adverse event as reported.
Fever of 102 degree at home the night of vaccine 2/24/09. Today in office 97.6 AX. Slightly swollen at site RVL, warm to touch, no redness. Hives on neck and back reported by mom, no hives/rash noted.
Patient was vaccinated at 10:30 am. She felt pain as vaccine was injected into the deltoid muscle, but that is typical. She was fine in the store but an hour and a half to two hours later she started to have bad pain in her left shoulder. It got to the point where she vomited and thinks that the pain is what caused it. By 2:00pm she called back and the pain was worse and she had very intense pain in her left shoulder. After speaking with her primary care physician it was decided that she go to the ER. Her pain was managed there with oxycodone and cyclobenzaprine. I spoke with the husband at 6:30pm and he said the medication was helping her arm. There was still significant pain but it was improving. I spoke with him again at 8:15pm and he said that the pain was quite a bit better and that patient was resting. We will follow up with her tomorrow to see how she is doing.
The patient developed a sensation of seeing bright sparkly spots in his vision that lasted a brief moment.  He said that this typically happens after he gets a shot or is exposed to needles.  He then asked if he could lay himself down because he says that is what usually helps him feel better.  His SBP was measured to be in the 80s initially with a heart rate in the low 50s.  His oxygen saturation was normal.  He was given some water to drink.   After a few minutes, his heart rate and blood pressure returned to normal.  We discussed having him go to the hospital.  After our evaluation, the patient preferred to go home.  We asked that he go to the hospital if his symptoms returned.
Approximately 2 days post immunizaiton 6/11/01 pt had temp 105 rectally and in ear *tympanic) and vomiting. Vomited from 6/11/01 until discharge from hospital. Acute febrile illness.
Approximately 3 hours after receiving Gardasil vaccine, patient's mother reports patient is hallucinating.  Denies chest pains, shortness of breath, palpitations or vomiting.  Patient was taken to the nearest ED for assessment.  Patient was seen in PCP's office for follow up 2 days later.
Redness, swollen, pain RD where Tdap was administered.  Resolved 2 days later (12/22/2012).
Negative COVID19 Virus test; Low grade fever; body aches; flu like symptoms; Lost sense of smell;  patient cannnot smell if someone is cutting grass next door; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), ANOSMIA (Lost sense of smell;  patient cannnot smell if someone is cutting grass next door), SARS-COV-2 TEST NEGATIVE (Negative COVID19 Virus test), PYREXIA (Low grade fever) and MYALGIA (body aches) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 045B21A.) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), ANOSMIA (Lost sense of smell;  patient cannnot smell if someone is cutting grass next door), PYREXIA (Low grade fever) and MYALGIA (body aches). On 30-Apr-2021, the patient experienced SARS-COV-2 TEST NEGATIVE (Negative COVID19 Virus test). On 26-Apr-2021, INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (Low grade fever) and MYALGIA (body aches) had resolved. At the time of the report, ANOSMIA (Lost sense of smell;  patient cannnot smell if someone is cutting grass next door) and SARS-COV-2 TEST NEGATIVE (Negative COVID19 Virus test) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: NNI